Dr Reddy's launches generic anti-bacterial drug in US

The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EiNp5cI
via IFTTT